News | July 13, 2022
Eversana partners with Compai Pharma to expand commercialisation services across APAC
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
The combined company will be able to better serve both our global and regional customers with local production
The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
The product will be launched by NATCO's commercial partner Viatris.
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
The Portal BioRRAP will cater to all those seeking regulatory approval for biological research
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
Subscribe To Our Newsletter & Stay Updated
